PBEvsFBTETF Comparison
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. PBE is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.54% for FBT. PBE is down -2.66% year-to-date (YTD) with -$2M in YTD flows. FBT performs better with -0.93% YTD performance, and +$1.07B in YTD flows. Run a side-by-side ETF comparison of PBE and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PBE vs FBT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE FBT | +4.27%+6.35% | -3.98%-6.86% | -2.66%-0.93% | +32.11%+29.41% | +28.24%+31.14% | +3.38%+24.73% |
| Flows | PBE FBT | +$2M-$20M | -$6M+$101M | -$2M+$1.07B | -$30M+$1.08B | -$58M+$617M | -$43M+$289M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE FBT | +19.57%+23.37% | +19.83%+21.80% | +20.15%+20.22% | +22.54%+21.89% |
| Max drawdown | PBE FBT | -9.36%-13.39% | -11.70%-14.27% | -22.21%-19.92% | -34.74%-29.98% |
| Max drawdown duration | PBE FBT | 75d87d | 107d91d | 324d237d | 1540d1243d |
PBE | FBT | |
Last sale 4/27/2026 at 4:03 PM | $80.57 | $204.75 |
| Previous close 04/24/2026 | $79.82 | $204.04 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PBE | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PBE | FBT | |
|---|---|---|
| Last price | $80.57 | $204.75 |
| 1D performance | +0.94% | +0.35% |
| AuM | $249.88 M | $2.31 B |
| E/R | 0.58% | 0.54% |
PBE | FBT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | First Trust |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | NYSE Arca Biotechnology Index |
| N° of holdings | 30 | 28 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | June 19, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
